INTRODUCTION AND OBJECTIVES: Radical cystectomy (RCE) shows the highest mortality and morbidity among urologic routine surgery. We analysed in-hospital outcomes of all RCE in Germany from 2006 to 2013 with a focus on the institutions' annual caseload and surgical approach.
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METHODS: By using remote data processing we analysed the nationwide German hospital billing data from 2006 to 2013. All cases with a bladder cancer diagnosis combined with RCE were eligible for evaluation. We calculated mortality and transfusion rates during the hospital stay and the length of stay. The results were stratified for hospital characteristics, caseload, and the surgical approach.
RESULTS: Total annual RCE numbers increased from 5,627 in 2006 to 7,399 in 2013. The share of open surgery declined from 99.3% to 96.6%, conventional laparoscopy increased from 0.7% to 1.6%, and the robot-assisted approach from 0% to 1.8%. The patients' mean age was 68.2 AE 9.9 years. The average in-hospital mortality rate was 4.5% for open RCE; in comparison it was lower with 3.8% for laparoscopic (p¼0.35) and 2.5% for robotic RCE (p¼0.002). Hospitals with high annual caseloads >50 RCE showed lower mortality rates with 3.3% vs. 4.1% (26-50 RCE), 5.0% (11-25 RCE), 5.2% (4-10 RCE), and 7.0% (<3 RCE) (p<0.001). The need for blood transfusion during the hospital stay was higher for open with 60.0% vs. laparoscopic 50.6% vs. robotic RCE with 35.9% (p<0.0001). The mean length of stay was longer for open with 25.3 days and laparoscopic RCE with 26.0 days vs. robotic RCE with 21.4 days (p<0.0001). Hospitals with high annual caseload >50 RCE showed a shorter hospital stay with 23.3 days vs. 24.7 days (26-50 RCE), 26.1 days (11-25 RCE), 26.3 days (4-10 RCE), and 24.5 days (<3 RCE) (p<0.0001). Multivariate models indicated that the patient's age and the type of urinary diversion were the most important factors for mortality and the need for blood transfusion (p<0.0001). Also on multivariate analysis hospitals with very low annual caseload (<3 RCE) had higher mortality (p¼0.02), blood transfusion (p¼0.0004), and a longer hospital stay (p<0.0001).
CONCLUSIONS: Hospitals with high annual caseload volumes show an improved outcome with lower rates of in-hospital mortality, blood transfusion, and a shorter hospital stay. Compared to the open approach robotic RCE showed lower rates of in-hospital mortality, blood transfusion and a shorter hospital stay. Whether this result is due to selection bias warrants further examinations. METHODS: Using the Premier Healthcare Database, we captured all patients who underwent a RC (ICD-9 code 57.71) from 2003 to 2015. To identify robot-assisted (RARC) and laparoscopic RCs (LRC), we performed a detailed review of the hospital chargemaster. Multivariable regression analyses were performed after adjusting for survey weighting and clustering to evaluate factors associated with RARC use.
RESULTS: Across the study period, there were a total of 71,844 RC (58, 779 ORC, 3847 LRC, 9218 RARC) . There is a gradual rise in the use of RARC from 0.1% in 2003 to 33.9% in 2015), overtaking the laparoscopic approach in 2009 (15.2% vs. LRC. Major (Clavien¼3) and overall (Clavien¼1) complication rates showed a rising trend up to 19.6% and 68.7% respectively in 2011 before plateauing (Figure 1) . Factors significantly associated with RARC include older age (OR 1.01, p¼0.03), male gender (OR 1.36, p¼0.01), married (vs. non-married, OR 1.23, p¼0.02), private insurance (vs. Medicare, OR 1.34, p<0.01), East North Central division (vs. South Atlantic, OR 2.13, p¼0.03), Middle Atlantic (OR 2.99, p¼0.01), hospital volume >90th percentile (>26/yr) (vs. ¼90th percentile, OR 2.10, p¼0.03) and later time period (vs. 2003 -2006 , OR for 2007 -2010 : 7.74, OR for 2011 -2015 . Patient with Charlson comorbidity index (CCI) ¼2 (vs. CCI 0, OR 0.71, p<0.01) and at West South Central division (OR 0.36, p¼0.04) were less likely to undergo RARC.
CONCLUSIONS: Currently, 1 in 3 RC cases are performed using robotic assistance. A variety of patient and hospital geographic characteristics appear to influence this increased utilization. This may be attributed to the acquisition of robotic surgical skills and familiarity with transperitoneal pelvic anatomy following the widespread use of robotic radical prostatectomy. METHODS: We performed a retrospective cohort study of patients who underwent cystectomy for cT2-cT4, N0 bladder cancer Vol. 197, No. 4S, Supplement, Sunday, May 14, 2017 THE JOURNAL OF UROLOGY â e725
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